BJDX — Bluejay Diagnostics Share News
0.000.00%
Last trade - 00:00Brief: Bluejay Diagnostics Inc On Sept 26, Agreed That Fisher Would Depart Company As An Employee And Cease Serving As Its CFO
Brief: Bluejay Diagnostics Regains Compliance With Nasdaq Minimum Bid Price Requirement
Brief: Bluejay Diagnostics Files For Mixed Shelf Of Up To $25 Mln - SEC Filing
Brief: Bluejay Diagnostics Inc Updated Clinical And Regulatory Strategy For Symphony Il-6 Biomarker Test
Brief: Bluejay Diagnostics Reports Q1 Results
Brief: Bluejay Diagnostics Signs Collaboration Agreement With Blood Centers Of America
Brief: Bluejay Diagnostics Inc Entered Into An Amendment To Company's Employment Agreement With CEO Neil Dey
Brief: Bluejay Diagnostics Reports Third Quarter Results
Brief: Bluejay Diagnostics Inc Reports Quarterly Loss Per Share Of $0.15
Brief: Bluejay Diagnostics Inc - Received Notification Letter From Nasdaq It Is Not In Compliance With Minimum Bid Price Requirement, On October 25, 2022
Brief: Bluejay Diagnostics, Inc. Reports Second Quarter 2022 Financial Results
Bluejay Diagnostics rises on completing sepsis test studies
Brief: Bluejay Completes Planned Clinical Studies For Symphony IL-6 Test
U.S. STOCKS ON THE MOVE-Novavax, Signet Jewelers, Zendesk, Roblox
U.S. STOCKS ON THE MOVE-Tesla, Roblox, Novavax, Couchbase
Brief: Bluejay Reports FDA Agrees To Consider Its Plan To Pursue A De Novo Regulatory Pathway For The Symphony Il-6 Test
U.S. STOCKS ON THE MOVE-Deere, Signet Jewelers, Tesla, Bluejay Diagnostics
Bluejay Diagnostics jumps as FDA agrees on device approval pathway
Brief: Bluejay Diagnostics Reports Q1 Loss Per Share $0.10